UCSF study finds COVID-19 produces prolonged symptoms, fewer fevers in pregnant women

ByABC7 News Staff KGO logo
Friday, October 9, 2020
UCSF releases initial findings of COVID-19 pregnancy study
UCSF researchers have released the preliminary results of their study on COVID-19's impact on infected pregnant women. They found fever was rarely the first symptom, and longer recovery times were common.

SAN FRANCISCO (KGO) -- Preliminary results are coming in from what's being called "the largest study ever" of COVID-19's effects on pregnant women, led by UCSF and UCLA scientists.

Researchers found that half of the 600 participants in the study had symptoms after three weeks, while 25% reported symptoms after eight weeks.

RELATED: UCSF scientists develop nasal spray to fight COVID-19

Unlike most COVID cases, only 12% of the pregnant participants reported fever as their first symptom, the authors found.

The most common first symptoms in the study included a cough and a sore throat, which 20 percent and 16 percent of participants reported respectively.

WATCH: UCSF researchers look to turn COVID-19's weapons against itself

The COVID-19 virus isn't just devastating, it's devastatingly clever, hijacking the power of our own cells in novel ways to make itself more dangerous. But now a team at UCSF is hoping to turn one of the virus's own weapons against it.

It took an average of 37 days for symptoms to ease.

Vanessa Jacoby is a UCSF doctor and senior author of the study.

"One of the main takeaways is, we want pregnant people and their providers to recognize that you don't need to wait for a fever to consider COVID-19 in pregnancy," Jacoby says, "The most common symptoms, again, were cough and sore throat."

The study launched on March 22.

RELATED: Bay Area moms, mothers-to-be, OB/GYN weigh-in on parenting in the age of COVID-19

Once completed, researchers will have substantial data on more than 1,300 participants, giving them a much better idea of the virus's impact on pregnant women.

Copyright © 2024 KGO-TV. All Rights Reserved.